Literature DB >> 7896007

Nitric oxide-related vasoconstriction in lungs perfused with red cell lysate.

N F Voelkel1, K Lobel, J Y Westcott, T J Burke.   

Abstract

The present study in isolated rat lungs demonstrates that nitric oxide gas (.NO, 70 nM) added to the perfusate containing a small amount of hemolysate [175 microliters of lysed red blood cells (RBC) per 50 ml of Earle's balanced salt solution (EBSS)] triggered profound and sustained vasoconstriction. Vasoconstriction was not observed when .NO was added to lungs perfused with washed intact rat or human RBC or with oxyhemoglobin (Hgb 20 microM). The presence of hemolysate in the perfusate also caused vasoconstriction in response to n-acetylcysteine (50 microM), glutathione (10(-4) M), or ascorbic acid (10(-4) M) and potentiated greatly the vasoconstrictor response to 5 mM KCl. Not only .NO, but also nitroprusside (SNP) or L-arginine and paradoxically three .NO synthesis inhibitors, including N-monomethyl L-arginine, L-NAME, and nitroblue tetrazolium, which have different mechanisms of action, each caused in the presence of hemolysate large vasoconstrictive responses. Hemolysate itself enhanced O2 consumption by slices of lung; no effects of this dose of .NO on lung slice respiration were seen in the absence of hemolysate. Both Hgb and hemolysate lowered perfusate cGMP levels to the same degree suggesting that the vasoconstrictive response was not due to unique effects of hemolysate on guanylyl cyclase. Addition of superoxide dismutase (SOD) and catalase (CAT) to the hemolysate containing perfusate, or addition of a cyclooxygenase or 5-lipoxygenase inhibitor, virtually abolished the .NO induced vasoconstriction. The latter data are consistent with the concept that exposure of the vasculature to hemolysate may result in the formation of peroxynitrite. However, SOD and CAT did not abolish the pulmonary vasoconstriction induced by L-arginine or by NAC. Our data indicate that hemolysate has profound effects on lung vessel tone regulation and on lung tissue mitochondrial function, yet the precise molecular mechanisms responsible for the action of hemolysate are likely to be very complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7896007     DOI: 10.1096/fasebj.9.5.7896007

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  4 in total

1.  Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension.

Authors:  Roberto F Machado; Sabrina Martyr; Gregory J Kato; Robyn J Barst; Anastasia Anthi; Michael R Robinson; Lori Hunter; Wynona Coles; James Nichols; Christian Hunter; Vandana Sachdev; Oswaldo Castro; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

2.  Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Authors:  N F Voelkel; R M Tuder; K Wade; M Höper; R A Lepley; J L Goulet; B H Koller; F Fitzpatrick
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

3.  Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.

Authors:  Jeffrey A Kline; Nury M Steuerwald; John A Watts; Mark Courtney; Herbert L Bonkovsky
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

4.  Nitric-oxide-mediated zinc release contributes to hypoxic regulation of pulmonary vascular tone.

Authors:  Paula J Bernal; Karanee Leelavanichkul; Eileen Bauer; Rong Cao; Annette Wilson; Karla J Wasserloos; Simon C Watkins; Bruce R Pitt; Claudette M St Croix
Journal:  Circ Res       Date:  2008-05-15       Impact factor: 17.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.